Maureen O'Connor

Board of Directors, Chair

Maureen O’Connor joins APIE-Therapeutics Inc as the Chairwomen of the Board of Directors.   Maureen O’Connor is a senior healthcare executive passionate about driving change in our health care system to improve lives.   She is currently the President & Founder at Moxie Health Care Advisory and most recently, Maureen served as president of Whiterabbit.ai, a Silicon-Valley based company with a mission to eradicate late stage breast cancer in five years through the use of artificial intelligence. The company’s suite of AI products ensures that more women are screened, cancer is detected earlier and more accurately, and the consumer experience is significantly enhanced. Before joining Whiterabbit.ai, Maureen spent 17 years as an executive with Blue Cross Blue Shield of North Carolina, serving as EVP of diversified businesses and president of Mosaic Health Solutions, the corporate venture arm of the company; chief strategy and innovation officer, responsible for clinical operations, health system innovation, data analytics and new business development. Prior to that time, she was general counsel and chief administrative officer.   

 

Maureen  received a law degree from Suffolk University Law School and a bachelor's degree in English from College of the Holy Cross.  Maureen serves in board and advisory roles for a number of health care technology and services companies nationally. She also is active on many professional and community boards including the Oliver Wyman Healthcare Innovation Leaders Alliance, the United Way of the Greater Triangle (chair) and Family House at UNC Hospitals. In the past she served on the board of the Council for Affordable Quality Healthcare (CAQH).  She was named by Triangle Business Journal as one of 12 “People to Watch” in 2014. Diversity Journal designated Maureen as one of the nation's "100 Women to Watch in 2009" and she was recognized in 2008 as one of 10 "Women Extraordinaire" in the Triangle by Business Leader magazine. 

© 2020 by Apie Therapeutics. 

  • LinkedIn